PATENT CLAIM ANALYSIS

Application Number: 15939952
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "233200"]

Abstract:
Compounds discovered through a high-throughput screen, along with methods of use of the compounds, are provided. The compounds can be used to strongly inhibit key drug targets found in protozoan parasites, e.g., the target  Trypanosoma cruzi  glucokinase. Compounds include derivatives of N-phenylbenzenesulfonamide, barbituric acid, (R)-3-(piperidin-2-yl)pyridine, 3-nitro-2-phenyl-2H-chromene, 6-amino-3-methyl-4-phenyl-1,4-dihydropryranole[2,3-c]pyrazole-5-carbonitrile, and gossypol (2,2′-Bis(formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene).

Claim (Index 11):
The pharmaceutical composition of  claim 10 , wherein the compound has one of the following structures:

Metadata:
- Claim Count in Document: 46.0
- Percentile: 90.0
- Lexical Diversity: 1.35088
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14405159', '11818224', '12356745', '14927390', '12412658']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.742461206887579
- 35 USC 102 Novelty (BERT): 0.5065342866614596
- Combined Prediction Score: 0.7188685148649671
- Mean Citation Score: 184.092424
- Max Citation Score: 185.51794
- Similarity Product: 106.02359179108022

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test